S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

ELOX Eloxx Pharmaceuticals Inc

3.82

0.00 (0.00%)

Last Updated: 18:00:00

Delayed by 15 minutes

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

Eloxx Pharmaceuticals (NASDAQ:ELOX)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Eloxx Pharmaceuticals Charts.

Eloxx Pharmaceuticals (NASDAQ:ELOX)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Eloxx Pharmaceuticals Charts.

Eloxx Pharmaceuticals Inc News

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Tuesday 20 August 2024 (5 months ago) • Edgar (US Regulatory)

Eloxx Pharmaceuticals Provides Pipeline and Financing Updates
Thursday 11 July 2024 (6 months ago) • GlobeNewswire Inc.

Eloxx Pharmaceuticals Provides ELX-02 and ZKN-013 Program Updates
Tuesday 16 April 2024 (9 months ago) • GlobeNewswire Inc.

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Monday 1 April 2024 (9 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 29 March 2024 (10 months ago) • Edgar (US Regulatory)

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Thursday 21 March 2024 (10 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 14 March 2024 (10 months ago) • Edgar (US Regulatory)

Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to license ZKN-013 for rare dermatological diseases
Wednesday 13 March 2024 (10 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Friday 26 January 2024 (12 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 26 January 2024 (12 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 26 January 2024 (12 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 26 January 2024 (12 months ago) • Edgar (US Regulatory)

More Eloxx Pharmaceuticals Inc News Articles

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions